Healthcare and Pharmaceuticals
Global Migraine Drugs Market was valued at USD XX Billion in the year 2017. Global Migraine Drugs Market is further estimated to grow at a CAGR of XX% from 2018 to reach USD XX Billion by the year 2023. North America region holds the highest market share in 2017 and Asia-Pacific is considered as the fastest growing market in the forecasted period. At a country level, developed markets like the U.S holds the notable market share in 2017 and it is projected to grow at a gradual rate in the coming years.
Endo International Plc. (U.S), Abbott (U.S), Johnson & Johnson Services, Inc. (U.S), Pfizer Inc. (U.S), Allergan Plc. (Dublin), Eisai Co., Ltd. (Japan), AbbVie Inc. (U.S), GlaxoSmithKline Plc. (U.K), Merck & Co., Inc. (U.S), AstraZeneca PLC (U.K), are some of the key players in the Migraine Drugs Market.
Increase in alertness among patients
Side effects of migraine drugs
Developing migraine therapies
Availability of raw materials
Segmentation done on the basis of Type includes Preventive Medicine and Abortive Medicine of which the Abortive Medicine segment is expected to hold the highest market share during the forecast period. On the other hand, segmentation done on the basis of Application includes Injection and Oral of which Oral segment is expected to grow at the highest CAGR during the forecast period.
Key Benefits for Stakeholders
Migraine Drugs Market manufacturers, dealers and suppliers
Migraine disease associations
Pharmaceutical and R&D laboratories,
Research and consulting firms.
Key Market Players
Endo International Plc.
Johnson & Johnson Services, Inc.
Eisai Co., Ltd.
Merck & Co., Inc.
(Another brief information of 10 companies will provided in report)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
220.127.116.11. Key Data from Secondary Research
2.1.2. Primary Research
18.104.22.168. Key Data from Primary Research
22.214.171.124. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottom-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Migraine Drugs Market, By Application
7. Migraine Drugs Market, By Types
7.1. Preventive Medicine
7.1.1. Beta Blocker
7.2. Abortive Medicine
7.2.1. Ergotamine Derivative
8. Migraine Drugs Market, By Distribution
8.1. Online Pharmacies
8.2. Retail Pharmacies
8.3. Hospital-based Pharmacies
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Endo International Plc.
10.3. Johnson & Johnson Services, Inc.
10.4. Pfizer Inc.
10.5. Allergan Plc.
10.6. Eisai Co., Ltd.
10.7. AbbVie Inc.
10.8. GlaxoSmithKline Plc.
10.9. Merck & Co., Inc.
10.10. AstraZeneca PLC
(Another brief information of 10 companies will be provided in the report)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
1.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
* The list of tables and figures will be provided in the sample report
No Content Available.